Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 7
Encontrada(s) 1 página(s)

Repisalud
Publicación Artículo científico (JournalArticle)

Genealogy, Dendritic Cell Priming, and Differentiation of Tissue-esident Memory CD8(+) T Cells

  • Enamorado, Michel
  • Khouili, Sofia C.
  • Iborra, Salvador
  • Sancho, David
Tissue-resident memory CD8(+) T (Trm) cells define a distinct non-recirculating subset. Trm cells constitute a first line of defense against local infections in barrier tissues, but they are also found in non-barrier tissues and play a role in antitumor immunity. Their differentiation in tissues and their phenotypical, transcriptional, and functional characteristics are the object of active research. Herein, we will discuss the potential existence of committed CD8(+) Trm precursors and the genealogy of memory CD8(+) T cell subsets. In addition to the priming of naive T cells, there is some plasticity of antigen-experienced effector and memory T cell subsets to generate Trm precursors. Local inflammation, antigen presentation, and cytokines drive Trm differentiation. It is of prime interest how specific dendritic cell subsets modulate priming and differentiation of Trm cells, as well as their reactivation within tissues. Research on how we can manipulate generation of memory T cells subsets is key for improved vaccination strategies.
Repisalud
Publicación Artículo científico (JournalArticle)

pDCs amplify tissue-resident memory CD8+ T cell responses during viral reinfection.

  • Hernández-García, Elena
  • Galán, Miguel
  • Khouili, Sofía C
  • Moya-Ruiz, Elena
  • Redondo-Urzainqui, Ana
  • Cueto, Francisco J
  • Martínez-Cano, Saraí
  • Rodrigo-Tapias, Manuel
  • Tomasello, Elena
  • Mañes, Santos
  • Dalod, Marc
  • Sancho, David
  • Iborra, Salvador
Resident memory CD8+ T cells (Trms) are essential for protecting barrier nonlymphoid tissues (NLTs) against reinfection, yet the involvement of dendritic cells (DCs) in this process and the nature of Trm-DC interactions within these tissues remain poorly understood. Our study demonstrates that upon reactivation, memory CD8+ T cells located in the skin-independently of circulating memory counterparts-initiate the infiltration and maturation of plasmacytoid DCs (pDCs) in the tissue. This, in turn, promotes the maturation of conventional type 1 DCs (cDC1s) through type I IFN (IFN-I) signaling in a pDC-dependent manner. Depletion of pDCs or blocking IFN-I signaling disrupts this axis, severely impairing Trm-driven protection against secondary infections with vaccinia virus (VACV) in the skin. Notably, this pDC-dependent, IFN-I-mediated pathway is also essential for Trm-mediated protection against secondary respiratory infections with influenza A virus (IAV). Our findings uncover a crucial collaboration between Trm, pDCs, and cDC1s, offering new insights for enhancing vaccines.
Repisalud
Publicación Artículo científico (JournalArticle)

Metabolic Control of Dendritic Cell Functions: Digesting Information

  • Wculek, Stefanie K
  • Khouili, Sofia C.
  • Priego, Elena
  • Heras-Murillo, Ignacio
  • Sancho, David
Dendritic cells (DCs) control innate and adaptive immunity by patrolling tissues to gather antigens and danger signals derived from microbes and tissue. Subsequently, DCs integrate those environmental cues, orchestrate immunity or tolerance, and regulate tissue homeostasis. Recent advances in the field of immunometabolism highlight the notion that immune cells markedly alter cellular metabolic pathways during differentiation or upon activation, which has important implications on their functionality. Previous studies showed that active oxidative phosphorylation in mitochondria is associated with immature or tolerogenic DCs, while increased glycolysis upon pathogen sensing can promote immunogenic DC functions. However, new results in the last years suggest that regulation of DC metabolism in steady state, after immunogenic activation and during tolerance in different pathophysiological settings, may be more complex. Moreover, ontogenically distinct DC subsets show different functional specializations to control T cell responses. It is, thus, relevant how metabolism influences DC differentiation and plasticity, and what potential metabolic differences exist among DC subsets. Better understanding of the emerging connection between metabolic adaptions and functional DC specification will likely allow the development of therapeutic strategies to manipulate immune responses.
Repisalud
Publicación Artículo científico (JournalArticle)

Effective cancer immunotherapy by natural mouse conventional type-1 dendritic cells bearing dead tumor antigen

  • Wculek, Stefanie K
  • Amores-Iniesta, Joaquin
  • Conde-Garrosa, Ruth
  • Khouili, Sofia C.
  • Melero, Ignacio
  • Sancho, David
BACKGROUND: The manipulation of dendritic cells (DCs) for cancer vaccination has not reached its full potential, despite the revolution in cancer immunotherapy. DCs are fundamental for CD8+ T cell activation, which relies on cross-presentation of exogenous antigen on MHC-I and can be fostered by immunogenic cancer cell death. Translational and clinical research has focused on in vitro-generated monocyte-derived DCs, while the vaccination efficacy of natural conventional type 1 DCs (cDC1s), which are associated with improved anti-tumor immunity and specialize on antigen cross-presentation, remains unknown. METHODS: We isolated primary spleen mouse cDC1s and established a protocol for fast ex vivo activation and antigen-loading with lysates of tumor cells that underwent immunogenic cell death by UV irradiation. Natural tumor antigen-loaded cDC1s were transferred and their potential for induction of endogenous CD8+ and CD4+ T cell responses in vivo, cancer prevention and therapy were assessed in three grafted cancer models. Further, we tested the efficacy of natural cDC1 vaccination in combination and comparison with anti-PD-1 treatment in two "wildtype" tumor models not expressing exogenous antigens. RESULTS: Herein, we reveal that primary mouse cDC1s ex vivo loaded with dead tumor cell-derived antigen are activated and induce strong CD8+ T cell responses from the endogenous repertoire upon adoptive transfer in vivo through tumor antigen cross-presentation. Notably, cDC1-based vaccines enhance tumor infiltration by cancer-reactive CD8+ and CD4+ T cells and halt progression of engrafted cancer models, including tumors that are refractory to anti-PD-1 treatment. Moreover, combined tumor antigen-loaded primary cDC1 and anti-PD-1 therapy had strong synergistic effects in a PD-1 checkpoint inhibition susceptible cancer model. CONCLUSIONS: This preclinical proof-of-principle study is first to support the therapeutic efficacy of cancer immunotherapy with syngeneic dead tumor cell antigen-loaded mouse cDC1s, the equivalents of the human dendritic cell subset that correlates with beneficial prognosis of cancer patients. Our data pave the way for translation of cDC1-based cancer treatments into the clinic when isolation of natural human cDC1s becomes feasible.
Repisalud
Publicación Artículo científico (JournalArticle)

SHP-1 Regulates Antigen Cross-Presentation and Is Exploited by Leishmania to Evade Immunity.

  • Khouili, Sofia C.
  • Cook, Emma CL
  • Hernández-García, Elena
  • Martínez-López, María
  • Conde-Garrosa, Ruth
  • Iborra, Salvador
Intracellular pathogens have evolved strategies to evade detection by cytotoxic CD8+ T lymphocytes (CTLs). Here, we ask whether Leishmania parasites trigger the SHP-1-FcRγ chain inhibitory axis to dampen antigen cross-presentation in dendritic cells expressing the C-type lectin receptor Mincle. We find increased cross-priming of CTLs in Leishmania-infected mice deficient for Mincle or with a selective loss of SHP-1 in CD11c+ cells. The latter also shows improved cross-presentation of cell-associated viral antigens. CTL activation in vitro reveals increased MHC class I-peptide complex expression in Mincle- or SHP-1-deficient CD11c+ cells. Neuraminidase treatment also boosts cross-presentation, suggesting that Leishmania triggers SHP-1-associated sialic-acid-binding receptors. Mechanistically, enhanced antigen processing correlates with reduced endosomal acidification in the absence of SHP-1. Finally, we demonstrate that SHP-1 inhibition improves CD11c+ cell-based vaccination against the parasite. Thus, SHP-1-mediated impairment of cross-presentation can be exploited by pathogens to evade CTLs, and SHP-1 inhibition improves CTL responses during vaccination.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Overcoming Antifungal Resistance: A Histatin 5-Gated Nanodevice for On-Demand Surfactant Delivery against Infections

  • Reyes-Torres, Miguel|||0000-0003-4751-2698
  • Hicke-García, Francisco Javier|||0000-0002-8419-0467
  • Escudero-Noguera, Andrea|||0000-0003-2670-6127
  • Sanz-Álvarez, Víctor|||0009-0004-7967-6552
  • Martínez-Bisbal, M.Carmen|||0000-0002-8526-4413
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Marcos Martínez, María Dolores|||0000-0001-7079-8589
  • Bernardos Bau, Andrea|||0000-0002-3842-5771
  • de Boer, Leonie
  • Zaat, Sebastian A. J.
  • Diez-Sánchez, Paula
[EN] The escalating incidence of fungal infections, coupled with the emergence of antifungal resistance, represents a formidable global public health challenge. is a common opportunistic fungus that causes life-threatening, widespread candidiasis, especially in immunocompromised patients. Conventional antifungals, including azoles, echinocandins, and polyenes, have some drawbacks, such as host toxicity and the rapid appearance of resistant fungal strains. To overcome these limitations, we engineered a stimuli-responsive gated antimicrobial nanoparticle using mesoporous silica nanoparticles, functionalized with the antimicrobial peptide histatin 5 (Hst5) and loaded with the surfactant (3-(methyl)-1-tetradecylimidazolium) [C14MIM]+. The nanoparticles exhibit potent antimicrobial activity against , with minimum inhibitory concentration values comparable to current clinical antifungals. Crucially, the nanodevice exhibits a dual mechanism of action, causing membrane disruption and inducing reactive oxygen species generation, which effectively hinders the development of resistance. Furthermore, the nanoparticles display strong synergistic interactions with conventional antifungals, significantly enhancing their efficacy. In addition to its planktonic activity, the system effectively inhibits biofilm formation and demonstrates high biocompatibility with human dermal cell lines. Based on these results, the nanodevice is successfully incorporated into a wound dressing matrix, demonstrating its promising translational potential for the topical treatment of cutaneous candidiasis., This research was supported by projects PID2021-126304OB-C41, PID2021-128141OB-C22, PID2024-155683OB-C41, and PID2024-162542OB-I00 funded by MCIN/AEI/10.13039/501100011033/ and by European Regional Development Fund-a way of funding Europe. This work was also supported by the European Research Council (ERC) via Advanced Grant (101,052,997, EDISON). This study formed part of the Advanced Materials program (MFA/2022/053) and the AGROALNEXT program (AGROALNEXT/2022/032), supported by MCIN with funding from the European Union NextGenerationEU (PRTR-C17 & centerdot;I1) and by Generalitat Valenciana. The study was also supported by Generalitat Valenciana (CIPROM/2021/007). This research was supported by CIBER, Consorcio Centro de Investigacion Biomedica en Red (CB06/01/2012). M.R.-T. thanks MIU for his FPU grant (FPU21/03142). F.J.H. thanks Ministerio de Universidades (MIU, Spanish Government) for his FPU grant (FPU20/06021). P.D. thanks the Instituto de Salud Carlos III and the European Social Fund for financial support "Miguel Servet" (CP24/00043).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Natural antimicrobials synergistically coupled with nanomotors: An innovative strategy for biofilm eradication

  • Medaglia, Serena|||0000-0003-3537-9842
  • Escudero-Noguera, Andrea|||0000-0003-2670-6127
  • Morella-Aucejo, Ángela|||0000-0002-6357-949X
  • Hicke-García, Francisco Javier|||0000-0002-8419-0467
  • Reyes-Torres, Miguel|||0000-0003-4751-2698
  • Bernardos Bau, Andrea|||0000-0002-3842-5771
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Marin-Ferrandis, Lucia
  • Amorós, Pedro
  • Marcos, MD
  • Diez-Sánchez, Paula
[EN] Biofilms are one of the most important problems occurring in industrial environments, especially in food industry. The possibility of foodborne disease outbreaks as a result of biofilm-food cross-contamination is a distinct concern, along with the substantial costs associated with food spoilage and biofilm control. Besides, despite daily cleaning and disinfection, many bacteria grow in machines and surfaces in food processing plants, some of them forming biofilms. A promising procedure for disinfection and biofilm elimination could be the use of hybrid antimicrobial nanomaterials endowed with motion (i.e., nanomotors). Herein, we report Janus nanoparticles based on the conjunction of platinum and mesoporous silica nanoparticles, functionalized with a derivative of a natural antimicrobial compound, vanillin. The engineered nanomotors combine H2O2-triggered self-propulsion with the antimicrobial activity of vanillin, allowing enhanced physical penetration into the 3D matrix formed by the exopolymeric substances generated in monospecies (Staphylococcus aureus) and multispecies (S. aureus and Escherichia coli) biofilms and the subsequent elimination of pathogenic cells., The Spanish Government (projects PID2021-126304OB-C41, PID2021-128141OB-C22 and TED2021-132114B-I00, MCUI/FEDER, EU and CIBER-Consorcio Centro de Investigacion Biomedica en Red (CB06/01/2012) , Instituto de Salud Carlos III, Ministerio de Ciencia Innovacion) and the Generalitat Valenciana (CIPROM/2021/007) funded this research. This work was also supported by the European Research Council (ERC) via Advanced Grant (101,052,997, EDISON) . This study formed part of the Advanced Materials program (MFA/2022/053) and the AGROALNEXT program (AGROALNEXT/2022/032) , supported by MCIN with funding from the European Union NextGenerationEU (PRTR-C17 & sdot;I1) and by Generalitat Valenciana. S.M. thanks the Generalitat Valenciana for her Grisolia fellowship (GRISOLIAP/2018/149) . A<acute accent>.M.-A. thanks the Universitat Politecnica de Valencia (UPV) for her Ph.D. grant (DOCEMPR22) . F.J.H thanks Ministerio de Universidades (MIU, Spanish Government) for his FPU grant (FPU20/06021) . M.R.-T. thanks MIU for his FPU grant (FPU21/03142) . A.B. thanks the MIU for her Beatriz Galindo contract (BG20/00020) . P.D.thanks the Instituto de Salud Carlos III and the European Social Fund for financial support "Sara Borrell" (CD20/00120) and "Miguel Servet" (CP24/00043) .